Spiramycin

Chemical formula: C₄₃H₇₄N₂O₁₄ Molecular mass: 843.065 g/mol PubChem compound: 6440717

Therapeutic indications

Spiramycin is indicated for:

Respiratory tract infections

Population group: only adults (18 - 65 years old)

Respiratory tract infection and additionally at least one of

Spiramycin susceptible species
Spiramycin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

6,000,000-9,000,000 IU in 2-3 divided doses daily

Chlamydial infection

Population group: only adults (18 - 65 years old)

Chlamydial infection

For this indication, competent medicine agencies globally authorize below treatments (click for details):

3.000.000 IU 2-3 times daily

Cryptosporidiosis

Population group: only adults (18 - 65 years old)

Cryptosporidiasis

For this indication, competent medicine agencies globally authorize below treatments (click for details):

6,000,000-9,000,000 IU in 2-3 divided doses daily

Toxoplasmosis

Population group: only adults (18 - 65 years old)

Toxoplasmosis

For this indication, competent medicine agencies globally authorize below treatments (click for details):

6,000,000-9,000,000 IU in 2-3 divided doses daily

Respiratory tract infections

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old)

Respiratory tract infection and additionally at least one of

Spiramycin susceptible species
Spiramycin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

150,000-300,000 IU/kg in 2-3 divided doses daily

Chlamydial infection

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old)

Chlamydial infection

For this indication, competent medicine agencies globally authorize below treatments (click for details):

150,000-300,000 IU/kg in 2-3 divided doses daily

Cryptosporidiosis

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old)

Cryptosporidiasis

For this indication, competent medicine agencies globally authorize below treatments (click for details):

150,000-300,000 IU/kg in 2-3 divided doses daily

Τοξοπλάσμωση

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old)

Toxoplasmosis

For this indication, competent medicine agencies globally authorize below treatments (click for details):

150,000-300,000 IU/kg in 2-3 divided doses daily

Meningococcal meningitis prophylaxis

Population group: only adults (18 - 65 years old)

Preventive procedure and additionally Epidemic meningitis

For this indication, competent medicine agencies globally authorize below treatments (click for details):

6,000,000 IU in 2 divided doses daily

Meningococcal meningitis prophylaxis

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old)

Preventive procedure and additionally Epidemic meningitis

For this indication, competent medicine agencies globally authorize below treatments (click for details):

150,000 IU/kg in 2-3 divided doses daily

Contraindications

Spiramycin is contraindicated in the following cases:

Lactation

Lactation

< Previous: Overview

Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈